StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research note issued on Monday. The brokerage set a “hold” rating on the stock.
China Pharma Price Performance
NYSE CPHI opened at $0.24 on Monday. The business has a fifty day simple moving average of $0.22 and a 200 day simple moving average of $0.26. China Pharma has a 12 month low of $0.17 and a 12 month high of $1.16. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.93 million during the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- Comparing and Trading High PE Ratio Stocks
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Breakout Stocks: What They Are and How to Identify Them
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- How to Use the MarketBeat Excel Dividend Calculator
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
